These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20089653)

  • 41. Simple strategy to induce antibodies of distinct specificity: application to the mapping of gp120 and inhibition of HIV-1 infectivity.
    Prieto I; Hervás-Stubbs S; García-Granero M; Berasain C; Riezu-Boj JI; Lasarte JJ; Sarobe P; Prieto J; Borrás-Cuesta F
    Eur J Immunol; 1995 Apr; 25(4):877-83. PubMed ID: 7737288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii.
    Pozzi G; Oggioni MR; Manganelli R; Medaglini D; Fischetti VA; Fenoglio D; Valle MT; Kunkl A; Manca F
    Vaccine; 1994 Sep; 12(12):1071-7. PubMed ID: 7998415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the outer domain of the gp120 glycoprotein from human immunodeficiency virus type 1.
    Yang X; Tomov V; Kurteva S; Wang L; Ren X; Gorny MK; Zolla-Pazner S; Sodroski J
    J Virol; 2004 Dec; 78(23):12975-86. PubMed ID: 15542649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120.
    Beddows S; Franti M; Dey AK; Kirschner M; Iyer SP; Fisch DC; Ketas T; Yuste E; Desrosiers RC; Klasse PJ; Maddon PJ; Olson WC; Moore JP
    Virology; 2007 Apr; 360(2):329-40. PubMed ID: 17126869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of HIV-1 IIIb neutralizing antibodies in BALB/c mice by a chimaeric peptide consisting of a T-helper cell epitope of Semliki Forest virus and a B-cell epitope of HIV.
    Fernández IM; Golding H; Benaissa-Trouw BJ; de Vos NM; Harmsen M; Nottet HS; Golding B; Puijk WC; Meloen RH; Snippe H; Kraaijeveld CA
    Vaccine; 1998 Dec; 16(20):1936-40. PubMed ID: 9796047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo alteration of humoral responses to HIV-1 envelope glycoprotein gp120 by antibodies to the CD4-binding site of gp120.
    Visciano ML; Tuen M; Gorny MK; Hioe CE
    Virology; 2008 Mar; 372(2):409-20. PubMed ID: 18054978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
    Bower JF; Green TD; Ross TM
    Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Attenuated Listeria monocytogenes carrier strains can deliver an HIV-1 gp120 T helper epitope to MHC class II-restricted human CD4+ T cells.
    Guzmán CA; Saverino D; Medina E; Fenoglio D; Gerstel B; Merlo A; Li Pira G; Buffa F; Chakraborty T; Manca F
    Eur J Immunol; 1998 Jun; 28(6):1807-14. PubMed ID: 9645361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV envelope antigen valency on peptide nanofibers modulates antibody magnitude and binding breadth.
    Fries CN; Chen JL; Dennis ML; Votaw NL; Eudailey J; Watts BE; Hainline KM; Cain DW; Barfield R; Chan C; Moody MA; Haynes BF; Saunders KO; Permar SR; Fouda GG; Collier JH
    Sci Rep; 2021 Jul; 11(1):14494. PubMed ID: 34262096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140.
    Stamatos NM; Mascola JR; Kalyanaraman VS; Louder MK; Frampton LM; Birx DL; VanCott TC
    J Virol; 1998 Dec; 72(12):9656-67. PubMed ID: 9811699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural and functional characterization of an epitope in the conserved C-terminal region of HIV-1 gp120.
    Ferrer M; Sullivan BJ; Godbout KL; Burke E; Stump HS; Godoy J; Golden A; Profy AT; van Schravendijk MR
    J Pept Res; 1999 Jul; 54(1):32-42. PubMed ID: 10448968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy.
    Law M; Cardoso RM; Wilson IA; Burton DR
    J Virol; 2007 Apr; 81(8):4272-85. PubMed ID: 17267498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.
    Alsahafi N; Debbeche O; Sodroski J; Finzi A
    PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.
    Kwong PD; Wyatt R; Robinson J; Sweet RW; Sodroski J; Hendrickson WA
    Nature; 1998 Jun; 393(6686):648-59. PubMed ID: 9641677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of the immunogenic properties of a single-chain polypeptide analogue of the HIV-1 gp120-CD4 complex in transgenic mice that produce human immunoglobulins.
    He Y; D'Agostino P; Pinter A
    Vaccine; 2003 Oct; 21(27-30):4421-9. PubMed ID: 14505925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Humoral immune response to immunocomplexed HIV envelope glycoprotein 120.
    Denisova G; Stern B; Raviv D; Zwickel J; Smorodinsky NI; Gershoni JM
    AIDS Res Hum Retroviruses; 1996 Jul; 12(10):901-9. PubMed ID: 8798975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The C108g epitope in the V2 domain of gp120 functions as a potent neutralization target when introduced into envelope proteins derived from human immunodeficiency virus type 1 primary isolates.
    Pinter A; Honnen WJ; D'Agostino P; Gorny MK; Zolla-Pazner S; Kayman SC
    J Virol; 2005 Jun; 79(11):6909-17. PubMed ID: 15890930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
    Sattentau QJ; Moore JP
    J Exp Med; 1991 Aug; 174(2):407-15. PubMed ID: 1713252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tryptophan 375 stabilizes the outer-domain core of gp120 for HIV vaccine immunogen design.
    Hu D; Bowder D; Wei W; Thompson J; Wilson MA; Xiang SH
    Vaccine; 2017 May; 35(23):3067-3075. PubMed ID: 28461065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of follicular helper T cells and the germinal center in HIV-1 gp120 DNA prime and gp120 protein boost vaccination.
    Hollister K; Chen Y; Wang S; Wu H; Mondal A; Clegg N; Lu S; Dent A
    Hum Vaccin Immunother; 2014; 10(7):1985-92. PubMed ID: 25424808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.